Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratracheal budesonide with surfactant to prevent bronchopulmonary dysplasia in very preterm infants
2020-005319-33Phase 3Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of budesonide in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Started Mar 2021; status: active.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on 2020-005319-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005319-33.